Business Wire

CORONA

23.7.2024 09:42:34 CEST | Business Wire | Press release

Share
Corona Cero Brings Same Seats as from Olympic Games Venues to Iconic Sunset Destinations Around the World

Today, Corona Cero, the global beer sponsor of the Olympic & Paralympic Games, unveils its Golden Venues activation, bringing the same seats as from the Olympic Games venues in Paris to iconic travel destinations across four continents. This initiative invites fans to reconnect with nature and gives them the opportunity to embrace their own Golden Moments every day as part of Corona Cero’s ‘For Every Golden Moment’ platform. This activation uses the same seats as from some of the Olympic Games venues in Paris, like Champ de Mars, Grand Palais, and Le Concorde and placed them in iconic travel destinations worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240722637366/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Greece - Corona Cero Golden Venues activation (Photo: Corona Cero)

The brand is featuring Golden Venues in 11 breath-taking outdoor settings across 9 countries, including renowned spots such as Arpoador beach in Rio de Janeiro, Brazil, the Grand Peninsula Lagonissi in Athens, Greece, and Café Del Mar in Cartagena, Colombia, offering panoramic views of their respective landscapes. The locations were selected for their remarkable sunsets, scenic beauty and cultural significance, offering visitors a unique opportunity to enjoy a touch of the Olympics amidst spectacular natural settings.

“From Greece, Brazil, Japan, South Africa and Argentina, Corona Cero is offering this gift to fans as an opportunity to experience the Olympic golden moment feeling through Golden Venues,” said Clarissa Pantoja, Vice President of Corona Global. “By bringing the same seats as from Olympic Games stadiums used throughout Paris to these incredible locations worldwide, we are reminding fans that golden moments not only exist within the Olympic Games, but also in the beauty of nature that’s around all of us.”

Corona, recognized as the world’s most valuable beer brand in Kantar’s BrandZ global 2024 rankings, has a rich history of promoting outdoor experiences and encouraging environmental stewardship. The brand is committed to fostering connections and creating meaningful moments in locations that resonate with fans globally.

The full list of Golden Venues spans:

Europe

  • Grand Peninsula Lagonissi in Athens, Greece, a popular beach and sailing destination on the Athenian Riviera with panoramic views of the Saronic Gulf;
  • Thames Riverfront in Battersea, London, UK, a bustling district with local and tourist attractions, including a riverside promenade, ecological areas, and sports facilities;

South America

  • Arpoador Beach in Rio de Janeiro, Brazil, next to Ipanema beach, this landmark destination is renowned for surfing and the best sunset views in town;
  • Café Del Mar in Cartagena, Colombia, located 150m high at the top of Old Town, Cafe Del Mar offers 360-views of Cartagena and is known for its stunning sunsets;
  • Coatepeque Volcano, El Salvador, a volcanic crater located 745 meters above sea level overlooking a 50,000 years old lake;
  • San Carlos de Bariloche, Argentina, a popular ski destination in the Argentinean Patagonia, surrounded by scenic forests and mountains;
  • Pichilemu in Punta de Lobos, Chile, a distinct beach with gray sand and large cliffs, Pichilemu is the heart of surf culture in Chile where many of the country's best surfers learned their skills;

Asia

  • Morito Beach in Kanagawa, Japan, known for its stunning views of Mt. Fuji, Morito Beach is one of the most famous spots on the coast of the Miura Peninsula;

Africa

  • South Africa (three locations) including Cape Town’s Signal Hill, offering panoramic views of V&A Waterfront, the Atlantic Ocean, Lion’s Head, and the iconic Table Mountain, one of the world's Seven Wonders of Nature.

“As the world anticipates the start of the Olympics, we are proud to see Corona Cero bring a touch of the Games to these global iconic locations for more fans to connect to their golden moments,” said Anne-Sophie Voumard, Managing Director IOC Television & Marketing Services. “We hope this gift will inspire people to embrace their own celebratory moments everyday!”

Fans can take in the beauty of nature while celebrating life’s golden moments – together with a refreshing Corona Cero served with a lime, or in any way they prefer to unwind and reconnect with nature. In select locations, the brand is also offering Sunset Hours, which are free concerts by local bands near the Golden Venues locations.

As the first-ever global beer sponsor of the Olympic Games, the no-alcohol beer brand is also elevating the role of moderation in Olympic celebrations globally, creating spaces and moments for cheers and choice in meaningful locations that matter to fans.

AB InBev brands have seen countless new friendships, connections, and experiences built on a shared love of sport and are pleased to be a part of that legacy with decades of historic, award-winning and responsible sports marketing.

The Golden Venues will be open to the public daily during the Olympic Games, starting July 23 with plans to remain in the area after the games.

###

About Corona Global
Corona, an AB InBev global brand*, is the iconic beer brand that is synonymous with paradise with a presence in 180 countries. Recognized as the world’s most valuable beer brand in Kantar’s BrandZ global 2024 rankings, Corona invites the world outside, beckoning you to reconnect with your essential nature and embrace the simple pleasures of life. But it's not just about the beer – it's about the ritual. The ritual of adding a slice of lime to your Corona, an experience that elevates the moment. Corona isn't just a beverage; it's nature in a bottle. And we strive to help protect nature and have become the first global beverage brand with a net-zero plastic footprint. This builds on our longstanding ambition to help protect the world’s oceans and beaches from plastic pollution. Every sip of Corona is a celebration of nature and the beauty of the world around us.

*Corona is not sold by AB InBev in the United States.

About The International Olympic Committee
The International Olympic Committee is a not-for-profit independent international organisation made up of volunteers, which is committed to building a better world through sport. It redistributes more than 90 per cent of its income to the wider sporting movement, which means that every day the equivalent of USD 4.25 million goes to help athletes and sports organisations at all levels around the world.

About AB InBev
AB InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 155,000 colleagues based in nearly 50 countries worldwide. For 2023, AB InBev’s reported revenue was 59.4 billion USD (excluding JVs and associates).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240722637366/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release

If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release

This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release

New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release

Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye